Insiders At Rocket Pharmaceuticals Sold US$2.0m In Stock, Alluding To Potential Weakness
The fact that multiple Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. When analyz
Simply Wall StApr 27 10:34 ET
Should You Retain Your Conviction in Rocket Pharmaceuticals (RCKT)?
Yahoo FinanceApr 24 11:33 ET
Rocket Pharmaceuticals(RCKT.US) Director Sells US$1.95 Million in Common Stock
$Rocket Pharmaceuticals(RCKT.US)$ Director SOUTHWELL DAVID P sold 80,000 shares of common stock on Apr 12, 15, 2024 at an average price of $24.322 for a total value of $1.95 million.Source: Announceme
moomoo NewsApr 16 18:29 ET
Rocket Pharmaceuticals Insider Sold Shares Worth $1,945,785, According to a Recent SEC Filing
David P Southwell, Director, on April 12, 2024, sold 80,000 shares in Rocket Pharmaceuticals (RCKT) for $1,945,785. Following the Form 4 filing with the SEC, Southwell has control over a total of 114,
MT NewswiresApr 16 17:50 ET
Form 144 | Rocket Pharmaceuticals(RCKT.US) Director Proposes to Sell 240.52K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 15, $Rocket Pharmaceuticals(RCKT.US)$、$ROCKET PHARMACEUTICALS INC C/WTS 02/09/2026 (TO PUR COM)(RCKTW.US)$ Director SOUTHWELL DAVID P intends to sell 10,000 shares of its c
moomoo NewsApr 15 16:21 ET
Form 144 | Rocket Pharmaceuticals(RCKT.US) Director Proposes to Sell 1.71 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 12, $Rocket Pharmaceuticals(RCKT.US)$、$ROCKET PHARMACEUTICALS INC C/WTS 02/09/2026 (TO PUR COM)(RCKTW.US)$ Director SOUTHWELL DAVID P intends to sell 70,000 shares of its c
moomoo NewsApr 12 16:14 ET
Rocket Pharmaceuticals Insider Sold Shares Worth $308,763, According to a Recent SEC Filing
Mark Andrew White, General Manager, Commercial Affairs, on April 08, 2024, sold 12,532 shares in Rocket Pharmaceuticals (RCKT) for $308,763. Following the Form 4 filing with the SEC, White has control
MT NewswiresApr 11 09:10 ET
Rocket Pharmaceuticals(RCKT.US) Officer Sells US$308.76K in Common Stock
$Rocket Pharmaceuticals(RCKT.US)$ Officer White Mark Andrew sold 12,532 shares of common stock on Apr 8, 2024 at an average price of $24.638 for a total value of $308.76K.Source: Announcement What is
moomoo NewsApr 10 21:21 ET
Optimistic Buy Rating for Rocket Pharmaceuticals Based on Strong Gene Therapy Pipeline and Expert Leadership
TipRanksApr 10 06:27 ET
Rocket Pharmaceuticals Price Target Maintained With a $53.00/Share by Needham
Rocket Pharmaceuticals Price Target Maintained With a $53.00/Share by Needham
Dow JonesApr 10 06:18 ET
Express News | Needham Reiterates Buy on Rocket Pharmaceuticals, Maintains $53 Price Target
Moomoo 24/7Apr 10 06:08 ET
Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM) and Rocket Pharmaceuticals (RCKT)
TipRanksApr 2 11:50 ET
Rocket Pharmaceuticals Initiated at Neutral by Goldman Sachs
Rocket Pharmaceuticals Initiated at Neutral by Goldman Sachs
Dow JonesApr 2 07:18 ET
Express News | Goldman Sachs Initiates Coverage On Rocket Pharmaceuticals With Neutral Rating, Announces Price Target of $39
Moomoo 24/7Apr 2 07:07 ET
Rocket Pharma Gains as EU Accepts Gene Therapy for Review
Seeking AlphaApr 2 06:55 ET
Express News | The European Medicines Agency Accepted The Marketing Authorization Application For Rocket Pharmaceuticals' RP-l102 For Fanconi Anemia
Moomoo 24/7Apr 2 06:04 ET
Hold Rating on Rocket Pharmaceuticals Amid Market Opportunity and Efficacy Questions for RP-A501
TipRanksApr 2 05:15 ET
Analysts Offer Insights on Healthcare Companies: Q32 Bio (QTTB) and Rocket Pharmaceuticals (RCKT)
TipRanksApr 2 05:00 ET
Rocket Pharmaceuticals Welcomes New CFO Aaron Ondrey
TipRanksMar 29 17:32 ET
Rocket Pharmaceuticals Appoints Aaron Ondrey as CFO
Seeking AlphaMar 26 16:07 ET
No Data
No Data